Sign in
4

Changes in Ownership

GALECTIN THERAPEUTICS INC Filed Acc 0001133416-23-000002

President and CEO acquired 15,487 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LEWIS JOEL · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-12-30 Grant or award : show line 1 in the form +15,487 $1.13 $17,500 698,867 D
Loading xslF345X03/form4.xml…